Barclays PLC Sells 156,955 Shares of GE HealthCare Technologies Inc. $GEHC

Barclays PLC trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,596,359 shares of the company’s stock after selling 156,955 shares during the period. Barclays PLC’s holdings in GE HealthCare Technologies were worth $130,933,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of GEHC. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $26,000. Optima Capital LLC bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $27,000. Godfrey Financial Associates Inc. bought a new stake in GE HealthCare Technologies during the fourth quarter valued at about $27,000. Montag A & Associates Inc. boosted its holdings in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC boosted its holdings in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 262 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $64.76 on Tuesday. The firm has a market capitalization of $29.46 billion, a PE ratio of 15.49, a price-to-earnings-growth ratio of 1.47 and a beta of 0.74. The firm has a 50-day moving average price of $66.21 and a 200 day moving average price of $75.07. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Analyst Ratings Changes

GEHC has been the subject of a number of recent analyst reports. Barclays decreased their price target on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Argus reduced their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Tuesday, May 19th. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Jefferies Financial Group reduced their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Finally, Stifel Nicolaus set a $80.00 target price on shares of GE HealthCare Technologies in a research note on Wednesday, April 29th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $80.21.

Insiders Place Their Bets

In related news, CEO Peter J. Arduini purchased 4,169 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Rodney F. Hochman purchased 1,618 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was bought at an average cost of $62.03 per share, with a total value of $100,364.54. Following the acquisition, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 21,847 shares of company stock valued at $1,361,355 over the last quarter. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.